Originally published In Press as doi:10.1074/jbc.M201014200 on March 23, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20717-20723, June 7, 2002
Opposing Roles for NF-
B/Rel Factors p65 and c-Rel in the
Modulation of Neuron Survival Elicited by Glutamate and
Interleukin-1
*
Marina
Pizzi
§,
Francesca
Goffi
,
Flora
Boroni
,
Marina
Benarese
,
Scott E.
Perkins¶
,
Hsiou-Chi
Liou**, and
PierFranco
Spano
From the
Division of Pharmacology and Experimental
Therapeutics, Department of Biomedical Sciences and Biotechnologies,
School of Medicine, University of Brescia, 25123 Brescia, Italy and the
** Department of Microbiology and Immunology and the
¶ Laboratory and Animal Facility, Weill Medical College of Cornell
University, New York, New York 10021
Received for publication, January 30, 2002, and in revised form, March 19, 2002
 |
ABSTRACT |
The nuclear transcription factors NF-
B/Rel
have been shown to function as key regulators of either cell death or
survival in neuronal cells. Here, we investigated whether selective
activation of diverse NF-
B/Rel family members might lead to distinct
effects on neuron viability. In both cultured rat cerebellar granule
cells and mouse hippocampal slices, we examined NF-
B/Rel activation induced by two opposing modulators of cell viability: 1)
interleukin-1
(IL-1
), which promotes neuron survival and 2)
glutamate, which can elicit toxicity. IL-1
produced a prolonged
stimulation of NF-
B/Rel factors by inducing both I
B
and
I
B
degradation. Glutamate produced a delayed and transient
activation of NF-
B/Rel, which was associated with a brief loss of
I
B
. Moreover, IL-1
activated the p50, p65, and c-Rel subunits
of NF-
B/Rel, whereas glutamate activated only the p50 and p65
proteins. The inhibition of NF-
B/Rel protein expression by antisense
oligonucleotides in cerebellar granule cells showed that p65 was
involved in glutamate-mediated cell death, whereas c-Rel was essential
for IL-1
-preserved cell survival. Furthermore, the depletion of
c-Rel in cultured neurons as well as in the hippocampus from the
c-Rel
/
mouse converted the IL-1
effect into
toxicity. These findings suggest that, within a single neuron, the
balance between cell death and survival in response to external stimuli
may rely on the activation of distinct NF-
B/Rel proteins.
 |
INTRODUCTION |
The transcription factors NF-
B/Rel play a key role in
regulating a diverse array of genes involved in cell growth,
differentiation, and adaptive responses to environmental factors that
are cell- and stimulus-specific (1). In the central nervous
system, NF-
B/Rel proteins are ubiquitously expressed in
neurons and glia (2, 3) where, in addition to regulating physiological
processes, they participate in pathological events associated with
neurodegeneration (3, 4). Increased NF-
B/Rel levels have been
observed in the dying neurons of brains exposed to trauma and ischemia
(5-8) as well as in brains of patients with Alzheimer's disease and Parkinson's disease (9-11). Whether NF-
B/Rel participates in a
neurodegenerative program or otherwise in a neuroprotective process by
increasing neuronal resistance to various noxae is still
debated. Although many studies support the anti-apoptotic effects of NF-
B/Rel in cultured neurons (12-15), conflicting
evidence has emerged from experimental models of pathological
conditions affecting adult neurons. For example, some studies showed
that NF-
B/Rel mediates the neuroprotection elicited by the tumor
necrosis factor in hippocampal cells (16, 17) and promotes neuronal resistance to excitotoxicity (18) and
-amyloid-induced apoptosis (19). Other studies demonstrated that the activation of NF-
B/Rel triggers neuronal degeneration after cerebral ischemia (6, 8) and
mediates the glutamate-activated cell death program during excitotoxic
insults to central neurons (4, 20, 21).
NF-
B/Rel proteins are a family of transcription factors composed of
several members, including p50, p52, p65/RelA, RelB, and c-Rel, that
form homo- and heterodimers capable of transmitting receptor signals to
the nucleus (3, 22). In resting cells, NF-
B/Rel factors are retained
in the cytoplasm by association with the inhibitory I
B proteins. In
stimulated cells, I
B is phosphorylated and degradated, thus allowing
the release and nuclear translocation of NF-
B dimers. Recently, a
more complex regulation of NF-
B/Rel activation that involves
modulatory phosphorylations has been emerging. The phosphorylation of
NF-
B/Rel components may operate to optimize their DNA binding and
transcriptional activities, as well as functional interaction with
coactivators (23). The diverse phenotypes of different NF-
B/Rel
knockout mice suggest that each NF-
B/Rel member serves unique
physiological roles in vivo, presumably via the regulation
of distinct sets of target genes. Thus, the opposite regulation of
neuron survival by NF-
B/Rel may very well depend on the activation
of a distinct combination of subunits, resulting in the differential
regulation of target genes and the induction of diverse genetic
programs that dictate the cell fate (24-26).
In this study, we investigated the contribution of different
NF-
B/Rel proteins to the cell survival of brain neurons exposed to
IL-1
1 and glutamate, two
common activators of NF-
B/Rel (27) that exert opposite effects on
neuronal viability. IL-1
, undetectable in healthy brains, increases
after a variety of neuronal insults. It was found to primarily elicit
neuroprotection against excitotoxicity at concentrations lower than
13,000 units/ml and exhibits toxicity only when applied for a prolonged
period at much higher concentrations (28). On the other hand, glutamate
is widely recognized for its ability to trigger neuronal cell
death and to mediate most neurodegenerative events in brain injuries
(29). We demonstrated here that the opposite effects of IL-1
and
glutamate on cell survival rely on the activation of different
NF-
B/Rel proteins. Glutamate activation of a p50/p65 dimer promoted
cell death, whereas IL-1
activation of p50/c-Rel, in addition to
p50/p65, preserved cell survival in both primary neurons and mouse
hippocampal slices. Treatment of the cells with p65 antisense
reduced glutamate-mediated cell death. The deletion of c-Rel, as in
c-Rel-null neurons, made IL-1
as toxic as glutamate. We conclude
that within a single neuron the balance between p65 and c-Rel
activation may account for the differential modulation of cell survival
elicited by glutamate and IL-1
.
 |
EXPERIMENTAL PROCEDURES |
Primary Neuronal Cultures--
Primary cultures of cerebellar
granule cells were prepared from 8-day-old rat cerebella
(Sprague-Dawley) (30). Experiments were carried out after culturing the
neurons for 12 days in vitro. In a neurotoxicity assay,
cultures were exposed to 100 µM glutamate or to 250 units/ml human recombinant IL-1
(Roche Molecular Biochemicals) for
15 min in Mg2+-free Locke's solution. Cell viability was
measured 18-24 h later by intravital staining with a fluorescein
diacetate (15 µg/ml) and propidium iodide (80 µg/ml) mixture and
was expressed as a percentage of the total cell number (30).
Hippocampal Slices from Adult Mice--
Hippocampal slices were
prepared from 40-day-old mice. C57BL/6 mice were purchased from Charles
River Italia, and c-Rel
/
mice (background strain
C57BL/6) were provided by H. -C. Liou (31). Animals were anesthetized
briefly with ether and decapitated. Hippocampi were rapidly removed and
cut at a thickness of 600 µm, and experiments were performed as
described previously (20, 33). Slices were submerged in 2 ml of Krebs
solution containing 11 mM glucose, equilibrated with 95%
O2, 5% CO2 (pH 7.4), and preincubated at
37 °C for 5 min. Then, 100 µM
N-methyl-D-aspartate (NMDA) was added, and
incubation was carried out for 15 min. At the end of this period,
slices were washed and further incubated in fresh buffer for 35 min.
When present, IL-1
was left for the entire period (50 min). At the
end of the experiment, slices were fixed and embedded in paraffin.
Sections were cut at a thickness of 5 µm, stained with methylene blue
and azure II, and examined by optical microscopy. To quantify cell
loss, adjacent cells were counted in cell layer fields taken from the
CA1 region of at least seven different slices for each treatment.
Normal pyramidal neurons were recognized by their characteristic size
and morphology. These neurons appeared to be homogeneous and compact
with a blue cytoplasm and a brighter nucleus. Lesioned neurons appeared
dark and pycnotic and were intermixed with edematous and vacuolated
cells. These cell layer fields measured 1.5 × 104
µm2. The percentage of cell survival was calculated as
the ratio of living cells to the total number of cells (33).
Nuclear Extract Preparation and Electrophoretic Mobility Shift
Assay (EMSA)--
Nuclear extracts were prepared as previously
described (34). Five µg of nuclear extracts were combined with 20,000 cpm (0.1 ng) of
32P-labeled
B oligonucleotides
(APP1, 5'-TAGAGACGGGGTTTCACCGTGTTA-3') in lipage buffer (17.5 mM HEPES, pH 7.5, 5 mM KCl, 103 mM
NaCl, 1 mM dithiothreitol, 0.35 mM EDTA, 10%
glycerol) containing 0.5 µg of poly(dI·dC) in a total volume
of 10 µl. In supershift experiments, nuclear proteins were incubated
with antibodies (4 µg) against different NF-
B subunits for 1 h at room temperature before the addition of the other components of
the reaction mixture. Incubation proceeded for an additional 20 min.
Rabbit polyclonal anti-p50 antibody was kindly provided by M. Grilli.
Polyclonal anti-p52, anti-p65, anti-RelB, and anti-c-Rel antibodies
were from Santa Cruz Biotechnology.
Synthetic Oligonucleotides--
Antisense phosphorothioate
oligodeoxynucleotides (ODNs) were synthesized by Sigma Genosys
(Cambridge, UK). The antisense sequences were
5'-ggggaacagttcgtccatggc-3' for p65, 5'-tacgcaccggaggccatggct-3' for
c-Rel, and 5'-ttaccgcgccgtagacgggca-3' for the scrambled
oligonucleotide (26). The ODN sequences exhibited no similarity to any
other known mammalian genes (BLAST search). Antisense ODNs (0.3 µM) were added as a complex with lipofectin (5 µg/ml,
Invitrogen) 18 h before the experiments at 37 °C in a 95%
O2, 5% CO2 atmosphere.
Western Blot Analysis--
Nuclear proteins (35) from the CA1
region of the hippocampal slices (50 µg/lane) and cell extracts from
cerebellar granule cells were resolved on SDS-PAGE, transferred to a
nitrocellulose membrane, and incubated with rabbit polyclonal anti-p65
(dilution 1:200) or anti-c-Rel (dilution 1:100) antibodies for 1 h. A secondary horseradish peroxidase-conjugated antibody (1:2000,
Santa Cruz Biotechnology) and ECL Western blotting reagents (Pierce)
were used for band detection. Immunoblot analysis of I
B proteins was performed on cytoplasmic proteins (35); 1 µM leupeptin,
10 µM aprotinin, and 1 µg/ml pepstatin were present
during the extraction procedure. The primary antibodies were
anti-I
B
and -I
B
(C-21 and C-20, respectively; 1:500
dilution; Santa Cruz Biotechnology). A secondary horseradish
peroxidase-linked antibody (1:1000) was used and visualized by ECL.
Immunostaining--
Primary cultures of cerebellar granule cells
were fixed in 4% paraformaldehyde in phosphate-buffered saline and
incubated with Triton X-100 (0.2% in phosphate-buffered saline) for 20 min. Hippocampal sections were deparaffinized, rehydrated in a series of ethanol concentrations, and incubated in methanol containing 10%
hydrogen peroxide for l0 min and with Triton X-100 (0.2% in phosphate-buffered saline) for an additional 20 min. Overnight incubation with polyclonal antibodies against p65 (1:100) or c-Rel (1:100) was performed at 4 °C. Biotinylated anti-rabbit
immunoglobulins (1:300, DAKO) and an ABC kit (DAKO) were used for
detection following the manufacturer's instructions. For double
immunofluorescence analysis, a monoclonal antibody against NeuN
(1:1000, Chemicon International) and polyclonal antibodies against p65
or c-Rel were used and detected, respectively, with Cy-2- and
Cy-3-marked secondary antibodies. Terminal
deoxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL) was
performed using the kit purchased from Roche Molecular Biochemicals
according to the manufacturer's instructions.
Statistics--
Data in all figures are expressed as means ± S.E. The values for cell viability are the means of at least three
separate experiments run in quadruplicate (primary cultures of
cerebellar granule cells) or in septuplicate (hippocampal slices). Data
were analyzed by Wilcoxon's rank sum test. p
0.05 was considered statistically significant.
 |
RESULTS |
Opposite Regulation of Neuron Survival by Glutamate and IL-1
in
Cerebellar Granule Cells Is Associated with a Distinct NF-
B/Rel
Activation Pattern--
In primary cultures of rat cerebellar granule
cells, a 15-min application of 100 µM glutamate in the
absence of extracellular magnesium has been well documented as reducing
cell survival by ~60% through activation of the NMDA type of
glutamate receptor (30). In this system, an application of 250 units/ml
IL-1
for 15 min (Fig. 3B, control), as well as for
24 h, did not affect cell viability but prevented glutamate
toxicity (data not shown) in line with previous evidence (28).
Despite their different effects on cell survival, both glutamate and
IL-1
activated NF-
B/Rel in cerebellar granule cells. Nuclear
extracts were prepared from replicate cultures 30 min, 1 h, and
3 h after the treatments (Fig.
1A) and then assayed by EMSA
for their DNA binding activity to the APP
B site from the APP gene (27). NF-
B/Rel induction elicited by
these two agonists displayed different kinetics, varying in the rate of
onset and persistence of NF-
B/Rel binding activity. As previously
described in cerebellar granule cells (27), within 30 min IL-1
highly activated APP
B binding activity that remained constant at
higher than the control level for 3 h. Glutamate activated
NF-
B/Rel in a slow and transient fashion; the activation was minimal
at 30 min, maximal at 1 h, and declined completely to the basal
level within 3 h.

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 1.
NF- B/Rel activation in cerebellar granule
cells. A, nuclear extracts from primary neurons were
analyzed by EMSA. This picture was taken from a
representative experiment showing the time course of NF- B/Rel
activation in vehicle- (C), glutamate- (G), and
IL-1 -treated (I) cells. Competition with a 100-fold
excess of APP B demonstrates the specificity of binding
(arrow). B, the effect of glutamate and IL-1
on I B and I B degradation in cerebellar granule cells.
Cytoplasmic extracts were prepared after the indicated times and
immunoblotted with specific antibodies directed against I B and
I B polyclonal antibodies. Immunoblots are from representative
experiments. Data from a densitometry analysis of immunoblots are
expressed as a percentage of control value and are expressed as
means ± S.E. of three separate experiments. *, p 0.05.
|
|
The difference in NF-
B/Rel activation kinetics in response to
glutamate and IL-1
was associated with differential degradation of
I
B
and I
B
. Cytoplasmic extracts were immunoblotted with specific I
B antiserum, and the blots were subjected to densitometry analysis (Fig. 1B). The level of I
B
appeared to
dramatically decrease 30 min after glutamate exposure and returned to
the control value within 1 h. No modification of the I
B
amount was produced by glutamate. In contrast, both I
B
and
I
B
levels rapidly reduced after IL-1
exposure and returned to
control levels within 3 h.
Distinct NF-
B/Rel Proteins Are Involved in the Opposing
Modulation of Cell Survival Elicited by Glutamate and IL-1
in
Cerebellar Granule Cells--
To investigate whether distinct
NF-
B/Rel proteins are important components of the signaling
machinery responsible for cell death or survival, we first established
the composition of the APP
B complex activated by glutamate and
IL-1
in primary neurons. We selected antibodies specific for
different members of the NF-
B/Rel family for their ability to
interfere with DNA binding activity (Fig.
2A). The p50 antiserum totally
inhibited the formation of the APP
B binding complex in both resting
and stimulated cultures and caused a slight supershifted band. The
anti-c-Rel antibody eliminated the majority of binding activity in
nuclear extracts from cells exposed to IL-1
but did not modify the
binding activity of nuclear extracts from cells treated with glutamate,
suggesting that only the IL-1
-induced complexes contain c-Rel. The
anti-p65 antibody significantly reduced the APP
B binding complexes
activated by both glutamate and IL-1
. Finally, anti-p52 and
anti-RelB antisera did not affect APP
B binding activity at all. The
densitometry analysis of EMSA results revealed the relative
contribution of individual NF-
B/Rel proteins to the APP
B binding
complexes (Fig. 2B). Glutamate preferentially induced
NF-
B/Rel dimers composed of p50 and p65 proteins, whereas IL-1
activated NF-
B/Rel dimers that contained p50, p65, and c-Rel
subunits.

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 2.
Characterization of
NF- B/Rel activation elicited by glutamate and
IL-1 in cerebellar granule cells.
A, EMSA and supershift analyses were performed in
vehicle-treated cells (C) and cells treated with glutamate
(G) or IL-1 (I). The molecular composition of
the NF- B/Rel complexes was investigated by incubating nuclear
extracts in the presence of antibodies raised against p52, RelB, p65,
c-Rel, and p50 subunits. The arrow and the
arrowhead indicate specific binding and supershift bands,
respectively. B, densitometry analyses of the NF- B/Rel
complexes from EMSA results. The values of binding activity were
expressed as a percent of the control value (vehicle-treated cells,
lane 1). Data are means ± S.E. of at least three
experiments carried out in different cell preparations. *,
p 0.05 versus corresponding binding
values obtained in the absence of an antibody (lane 1 for
control, lane 2 for glutamate, lane 3 for
IL-1 ).
|
|
To determine the role of p65 and c-Rel in glutamate and IL-1
modulation of neuron survival, cerebellar granule cells were pretreated
for 18 h with selective antisense ODNs directed to c-Rel or p65
subunits or with a scrambled ODN. Antisense ODNs to p65 and c-Rel
efficiently reduced the relative protein amounts as detected by either
immunocytochemical (Fig. 3A)
or immunoblot (Fig. 3B) analysis of treated cells. In
particular, p65 antisense ODN specifically reduced p65 expression
without modifying the c-Rel content (Fig. 3B). Likewise,
c-Rel antisense ODN suppressed c-Rel but not p65 expression.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of the antisense ODN to p65 and c-Rel
on glutamate and IL-1 modulation of cell
survival. Cerebellar granule cells were treated for 18 h with
specific antisense ODNs (AS) or with scrambled ODNs
(scr). A, immunoreactivity to p65 and c-Rel was
particularly evident in the cytoplasm of resting neurons
(arrows), although it was also present in the nucleus.
Treatments with p65 AS and c-Rel AS abolished the immunoreactivity to
respective target proteins. No modification was produced by scrambled
ODN. B, cell extracts from control and AS-treated cells were
immunoblotted against p65 and c-Rel antibodies. Both p65 AS and c-Rel
AS produced a specific decrease of the target protein. Blots reprobed
with an anti- -tubulin antibody indicated equal amounts of proteins
in the different lanes (data not shown). C, after ODN
treatment, cells received a 15-min pulse of glutamate or IL-1 , and
18 h later they were evaluated for cell viability by propidium
iodide and fluorescein diacetate intravital staining. Percentages of
cell survival after exposure to glutamate or IL-1 in control, c-Rel
AS-, p65 AS-, or scrambled ODN-treated cultures were quantified.
Similar results were obtained in three separate experiments run in
quadruplicate. *, p <0.05 versus the
corresponding control value.
|
|
In both control or scrambled ODN-pretreated cultures, glutamate reduced
cell survival to ~40%, whereas IL-1
produced no toxicity (Fig.
3C). In cultures exposed to c-Rel antisense ODN, neither the
viability of resting cells nor glutamate toxicity appeared to be
modified. Rather, cells pretreated with c-Rel antisense displayed a
high vulnerability to IL-1
application. Conversely, pretreatment
with p65 antisense ODN completely prevented glutamate-mediated toxicity
without affecting the viability of both resting and IL-1
-treated cells (~90% of cell viability). These experiments suggest that p65
is involved in glutamate-mediated toxicity, whereas c-Rel is crucial
for maintaining neuron survival upon IL-1
stimulation.
IL-1
Preserves Neuron Survival in the Hippocampus of Wild Type
Mice but Is Toxic to the Hippocampus of c-Rel Knockout Mice--
We
next investigated the modulation of neuron survival elicited by
glutamate and IL-1
in hippocampal slices from the adult mouse brain,
a system that more closely represents in vivo conditions. The exposure of hippocampal slices to the glutamate receptor agonist, NMDA (100 µM), for 15 min followed by a recovery period
of 35 min damaged about 70% of CA1 pyramidal neurons (Fig.
6C). Lesioned neurons showed internucleosomal DNA
fragmentation as revealed by a TUNEL assay (Fig.
4A). This effect was not
observed by a 50-min exposure to either 500 (data not shown) or 1000 units/ml IL-1
(Figs. 4A and 6E).

View larger version (85K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of NMDA and IL-1
on neuron survival and NF- B/Rel
activation in the CA1 region of hippocampal slices from C57BL/6
mice. After a 15-min exposure to NMDA (100 µM),
hippocampal slices were left to recover for 35 min in fresh
buffer. Exposure to IL-1 (1000 units/ml) was maintained for
the entire period (50 min). A, immunohistochemistry and
TUNEL labeling in the CA1 region of mouse hippocampal slices. Cells of
the pyramidal layer appear immunopositive to the specific neuronal
marker NeuN. Cell nuclei were particularly stained. The TUNEL labeling
of CA1 neurons indicates the presence of DNA fragmentation in the
nuclei of slices exposed to NMDA (arrows) but not in control
or IL-1 treated slices (arrows). B, Western
blot analysis of the p65 and c-Rel proteins in nuclear extracts of
hippocampal slices. At the end of the experiments, the CA1 regions of
hippocampi were dissected from the slices and used for the preparation
of nuclear extracts. The NMDA treatment increased the nuclear amount of
the p65 subunit, whereas IL-1 stimulation increased the nuclear
levels of both p65 and c-Rel. Blots reprobed with an anti- -tubulin
antibody indicated equal amounts of proteins in the different lanes
(data not shown). C, double immunofluorescence analysis of
NF- B activation in the CA1 region of mouse hippocampal slices.
Antibodies to NeuN (Cy-2 green) and c-Rel or p65 (both Cy-3
red) demonstrate colocalization. The nuclear localization
(arrows) of NF- B proteins in hippocampal neurons
indicates that NMDA stimulation activates only the p65 subunit,
whereas IL-1 exposure promotes the nuclear translocation of both p65
and c-Rel proteins.
|
|
NMDA and IL-1
rapidly induced the nuclear accumulation of
NF-
B/Rel proteins. The immunoblotting of nuclear extracts prepared at the end point of the experiment revealed increased levels of the p65
subunit by both treatments, but increased levels of c-Rel occurred only
with IL-1
treatment (Fig. 4B). To further investigate the
distinct activation of p65 and c-Rel in neurons, we applied the
immunocytochemical technique. This type of single cell analysis is
superior when studying signal transduction in brain slices because it
helps to identify the cell types involved. Double labeling with
antibodies against the neuron-specific NeuN protein and p65 or c-Rel
indicated colocalization in neuronal cells (Fig. 4C). The
hippocampal neurons of unstimulated sections displayed staining of the
two NF-
B/Rel subunits in the cytoplasm but weak or no staining in
the nuclei (Fig. 4C). Exposure to NMDA induced a marked increase of immunoreactivity for p65 but not for c-Rel in the nuclei.
In comparison, exposure to IL-1
increased the nuclear staining for
both p65 and c-Rel.
To confirm the functional relevance of c-Rel in the prosurvival effects
of IL-1
, we used mice deficient in the c-Rel protein (c-Rel
/
). Mice with a targeted disruption of this
subunit have no developmental abnormalities and only demonstrate
specific defects in immune responses (31). The immunoblotting of
c-Rel
/
brain extracts confirmed the lack of the c-Rel
protein (Fig. 5A). Hippocampal
slices from wild type (WT) and c-Rel
/
mice were exposed
to NMDA, IL-1
, or both and were examined for p65 activation and cell
viability. Similar to the occurrences in WT slices, either NMDA or
IL-1
activated the p65 subunit (Fig. 5B) in
c-Rel
/
hippocampal neurons, suggesting that the
deletion of c-Rel did not compromise the NF-
B machinery that leads
to the nuclear translocation of p65. By evaluating the cell viability,
we found that the property of NMDA to induce neuronal cell death was
comparable in both WT (Fig.
6C) and c-Rel
/
(Fig. 6D) slices. Conversely, significant differences in the two groups were disclosed by IL-1
exposure. As expected, IL-1
elicited no toxicity (Fig. 6E) but rather prevented
NMDA-mediated neuronal damage in WT slices (Fig. 6G). In
contrast, in c-Rel
/
hippocampal slices, IL-1
did not
display any protection when added in combination with NMDA (Fig.
6H). Moreover, it caused toxicity even when added alone
(Fig. 6F). The quantitation of pyramidal cell loss in the
CA1 region of WT and c-Rel
/
hippocampal slices after
the different treatments is shown in Fig. 6I. These results
further support the crucial role of c-Rel in the prosurvival effect
elicited by IL-1
in neuronal cells.

View larger version (128K):
[in this window]
[in a new window]
|
Fig. 5.
NF- B in hippocampal
slices from c-Rel knockout mice. A, Western blot
analysis of the c-Rel protein in total brain extracts from WT and
c-Rel / mice. B, p65 immunoreactivity was
absent in cell nuclei (arrows) of vehicle-treated
hippocampal slices from c-Rel / mice but increased in
slices exposed to either NMDA (100 µM) or IL-1 (1000 units/ml) or both drugs.
|
|

View larger version (88K):
[in this window]
[in a new window]
|
Fig. 6.
IL-1 (1000 units/ml)
elicits neuroprotection against NMDA (100 µM)-mediated excitotoxicity in
hippocampal slices from WT mice but exerts toxicity in slices from
c-Rel / mice (c-Rel / ). Photographs
were taken from the CA1 region of hippocampal sections stained with
methylene blue and azure II. A and B,
vehicle-treated slices. C and D, slices exposed
to NMDA. E and F, slices exposed to IL-1 .
G and H, slices exposed to NMDA plus IL-1 .
Superimposable results were obtained from three separate experiments.
Graph, a quantitative analysis of NMDA and IL-1 -induced cell loss in
the CA1 hippocampal region of WT and c-Rel / mice. *,
p < 0.05 versus the corresponding values of WT
group.
|
|
 |
DISCUSSION |
The common participation of NF-
B/Rel in either cell survival
(16, 17, 32) or cell death programs (6, 8, 20, 21) strongly supports
the relevance of this signaling pathway in regulating neuronal
vulnerability. The data presented here demonstrate that the activation
of distinct NF-
B/Rel proteins can yield an opposite modulation of
neuron survival. The nuclear translocation of dimers containing p50 and
p65 subunits, as triggered by glutamate, is associated with cell death.
Additional activation of the c-Rel subunit, as induced by IL-1
,
switches the cell response from death to survival.
The study was conducted both on primary cultures of pure cerebellar
granule cells and in hippocampal slices from adult mice. In both
models, NMDA receptor activation by excitatory amino acids could cause
neuronal degeneration (30), whereas the IL-1
cytokine preserved cell
survival and protected against excitotoxic injury (28). The
characterization of NF-
B/Rel activation elicited by the two stimuli
revealed significant kinetic differences. Glutamate induced a delayed
and transient stimulation of NF-
B/Rel, whereas IL-1
produced a
more persistent effect. The transient activation of NF-
B mediated by
glutamate correlated with a brief loss of I
B
as described
previously in striatal neurons (36). The sustained translocation of
NF-
B/Rel promoted by IL-1
, however, was associated with both
I
B
and I
B
degradation. The difference in NF-
B/Rel activation kinetics by the two stimuli may be partially explained by
the diverse features of I
B
and I
B
. Indeed, because
I
B
is a
B-responsive gene, upon
NF-
B/Rel stimulation the protein can rapidly recover and accumulate
in the cytoplasm via an autoregulatory feedback loop (22). In addition,
the newly synthesized I
B
can shuttle between the nucleus and the
cytoplasm, thus operating an active export of NF-
B/Rel
proteins from the nucleus through interaction with the nuclear export
receptor CRM1 (37). These properties are not shared by I
B
(37),
which is less efficient in exporting nuclear NF-
B/Rel proteins and
can allow a persistent activation of the transcription factor (22).
The different kinetics of NF-
B/Rel in response to glutamate and
IL-1
were associated with the activation of distinct NF-
B/Rel proteins to form active
B binding dimers. Excitotoxic stimuli mainly
activated p50 and p65 subunits, as previously found in the hippocampus
from kainate-injected mice (18) or in mouse brains exposed to focal
ischemia (8). In contrast, IL-1
activated dimers mainly composed of
p50, p65, and c-Rel proteins. The complete disappearance of the
NF-
B/Rel binding complex in nuclear extracts supershifted with the
p50 antibody suggests a common participation of p50 to form both
p50/p65 and p50/cRel dimers.
To delineate the specific involvement of different NF-
B subunits in
mediating cell death or cell survival, we treated primary neuronal
cultures with antisense oligonucleotides directed to p65 or c-Rel
proteins. The antisense technique was successfully applied to
demonstrate specific NF-
B/Rel regulation of proinflammatory mediators in peripheral cells (26). We found a differential role of p65
and c-Rel in modulating neuronal survival. Antisense to p65 completely
reversed glutamate-mediated cell death. Antisense to c-Rel showed no
effect on glutamate injury but did convert IL-1
neuroprotection into
toxicity. The functional balance between c-Rel and p65 in
IL-1
-promoting cell survival was further supported by experiments on
hippocampal slices from c-Rel
/
mice. The lack of the
c-Rel subunit did not compromise either p65 activation by both stimuli
or NMDA-mediated toxicity. Conversely, the knockout of the c-Rel
protein made hippocampal neurons become vulnerable to IL-1
. Thus, by
specifically targeting the p65 or the c-Rel subunit, the opposite
regulation elicited by NF-
B/Rel on cell survival of mature neurons
was unmasked. Dimers mainly composed of p50 and p65 can mediate
neuronal death. The inclusion of c-Rel in a dimer combination switches
the NF-
B/Rel effect into neuroprotection. Consistent with this
proposal, c-Rel overexpression mediates cell viability and reproduces
the anti-apoptotic response of the nerve growth factor in sympathetic
neurons (14) or of insulin-like growth factor-1 in immortalized
hippocampal cells and in cerebellar granule cells (38). Finally, the
common participation of p50 in both cell death and cell survival dimers
might account for the opposing results reported on neuron vulnerability
in p50 knockout mice (8, 18).
To our knowledge, these data provide the first direct evidence for a
dual role for NF-
B/Rel proteins as either cell death- or cell
survival-promoting factors within a single neuron. Moreover, they
demonstrate that the activation of distinct NF-
B/Rel proteins can be
a functional "end point," dictating neuronal cell death or survival
in response to external stimuli.
These findings raise and leave unanswered many general questions. The
mechanisms by which glutamate and IL-1
regulate specific NF-
B/Rel
dimers remain elusive, as well as the mechanism by which they
differently regulate the breakdown of I
Bs. Here, we report that the
calcium-permeable NMDA receptor channel can only engage in I
B
degradation. This can presumably occur via activation of the canonical
IKK
·IKK
·IKK
complex as well as by activation of
more cell type- and stimulus-specific I
B kinases (39). A recent
study that investigated the NMDA receptor-mediated activation of
NF-
B in striatal neurons likewise reported a selective degradation of I
B
(36). Because the participation of proteasomes in
NMDA-mediated I
B
degradation appeared negligible, the existence
of an alternative signaling pathway was also thought to contribute to
NF-
B induction in neurons exposed to excitotoxic stimuli (36). Based
on structural information, it has been shown that I
B
and I
B
differentially associate with homo-and heterodimers containing c-Rel
and p65 (22, 40), although to date most of the divergence appears in
their capability to respond to incoming signals and to dictate the
timing of the onset and duration of the response (22, 37). Thus, it is
likely that IL-1
, by activating different signal transduction
pathways from NMDA receptors such as the phosphatidylinositol 3-kinase/AKT pathway, may engage the activation of different IKK complexes that trigger both I
B
and I
B
degradation (22, 39) in addition to direct NF-
B/Rel subunit phosphorylation and
transactivation (23, 41). Identifying specific IKK complexes that
associate with each type of receptor, together with all IKK molecular
targets, will help clarify the issue of NF-
B/Rel subunit specificity.
How specific NF-
B proteins might exert opposing regulation of neuron
survival is another topic of primary importance. Indeed, in conjunction
with the selective activation of NF-
B/Rel complexes, other
regulatory mechanisms may contribute to the specificity of the
NF-
B/Rel response. NF-
B/Rel proteins can cooperate with a large
number of heterologous transcription factors to either enhance (such as
with the CCAAT/enhancer-binding protein
, SP1, and members of
Fos/Jun family) or repress (such as with Egr1) NF-
B-mediated
transactivation (24, 42). In addition, the NF-
B function may
be modulated through interaction with non-DNA binding transcriptional
co-activators, such as the p300/CREB-binding protein, or through
phosphorylation of NF-
B subunits achieved by signaling pathways that
modulate transcription activities (23, 24, 41). All these regulatory
mechanisms may integrate NF-
B/Rel activation with other signaling
molecules, thus adding selectivity and specificity to cell response. It
is not known whether and which of these mechanisms operate in neurons
exposed to glutamate or IL-1
.
Among the
B-responsive genes possibly involved in the control of
neuronal cell death, various pro-apoptotic genes such as p53, c-Myc, or the Fas ligand and its receptor
(FAS/CD95) genes are activated upon excitotoxic stimulation (4, 8, 21) and might mediate NF-
B/Rel-induced cell death in neurons. On the
other hand, other NF-
B/Rel target genes endowed with anti-apoptotic function might be involved in NF-
B-promoted neuron survival. These
include the manganese superoxide dismutase (16), which is responsive to
IL-1
in insulin-producing cells (43), the calcium-binding protein
calbindin (44), members of the inhibitors of apoptosis (IAP) family
(45), and Bcl-xL and Bfl-1, two members of Bcl2 family
acting at the mitochondrial level (46-49). In particular, manganese
superoxide dismutase (50) or Bcl-xL and Bfl-1 (46-48) were
found to be direct transcriptional targets of the c-Rel protein. Most
of this evidence has been obtained in non-neuronal cells. However, a
recent study also suggests that in the hippocampus, p50/c-Rel
activation after hypoxia is associated with Bcl-xL
expression. In that situation, hippocampal neurons display higher cell
resistance to hypoxia when compared with basal forebrain neurons,
wherein only p50/p50 and p50/p65 dimers are activated (51). Thus, the possibility that these groups of genes may be differentially
involved in the opposing modulation of neuron survival by glutamate and IL-1
is intriguing and deserves further investigation. Understanding how distinct NF-
B/Rel dimers can differently switch on arrays of
cell death or cell survival genes by acting individually or cooperatively with other transcriptional factors might have a relevant
implication for intervention in neurodegenerative diseases.
 |
ACKNOWLEDGEMENT |
We thank Mariagrazia Grilli for the helpful
discussion and for donating the p50 antibody.
 |
FOOTNOTES |
*
This work was supported by grants from the Consiglio
Nazionale delle Richerche (CNR 2000), the Italian Health Ministry, the Italian Ministry of University and Scientific and Technologic Research
(MURST; Confinanziamento (COFIN) 98 and 2000), and the MURST Center of
Excellence for Innovative Diagnostics and Therapeutics (IDET) of
Brescia University.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Biomedical
Sciences and Biotechnologies, Via Valsabbina 19, 25123 Brescia, Italy.
Tel.: 39-030-3717501; Fax: 39-030-3701157; E-mail: pizzi@med.unibs.it.
Present address: Division of Laboratory Animal Medicine, Tufts
University School of Medicine, Boston, MA 02111
Published, JBC Papers in Press, March 23, 2002, DOI 10.1074/jbc.M201014200
 |
ABBREVIATIONS |
The abbreviations used are:
IL-1
, interleukin-1
;
APP, amyloid precursor protein;
NMDA, N-methyl-D-aspartate;
EMSA, electrophoretic
mobility shift assay;
ODN, oligodeoxynucleotide;
TUNEL, terminal
deoxynucleotidyltransferase-mediated dUTP nick end-labeling;
WT, wild-type;
IKK, I
B kinase;
NeuN, neuron-specific nuclear
protein.
 |
REFERENCES |
| 1.
|
Liou, H.-C.,
and Baltimore, D.
(1993)
Curr. Opin. Cell Biol.
5,
477-487[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kaltschmidt, B.,
Baeuerle, P. A.,
and Kaltschmidt, C.
(1993)
Mol. Aspects Med.
14,
171-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
O'Neill, L. A. J.,
and Kaltschmidt, C.
(1997)
Trends Neurosci.
20,
252-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Grilli, M.,
and Memo, M.
(1999)
Cell Death Differ.
6,
22-27[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Terai, K.,
Matsuo, A.,
McGeer, E. G.,
and McGeer, P. L.
(1996)
Brain Res.
739,
343-349[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Clemens, J. A.,
Stephenson, D. T.,
Smalstig, E. B.,
Dixon, E. P.,
and Little, S. P.
(1997)
Stroke
28,
1073-1080[Abstract/Free Full Text]
|
| 7.
|
Bethea, J. R.,
Castro, M.,
Keane, R. W.,
Lee, T. T.,
Dietrich, W. D.,
and Yezierski, R. P.
(1998)
J. Neurosci.
18,
3251-3260[Abstract/Free Full Text]
|
| 8.
|
Schneider, A.,
Martin-Villalba, A.,
Weih, F.,
Vogel, J.,
Wirth, T.,
and Schwaninger, M.
(1999)
Nat. Med.
5,
554-559[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Terai, K.,
Matsuo, A.,
and McGeer, P. L.
(1996)
Brain Res.
735,
159-168[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Hunot, S,
Brugg, B.,
Ricard, D.,
Michel, P. P.,
Muriel, M. P.,
Ruberg, M.,
Faucheux, B. A.,
Agid, Y.,
and Hirsch, E. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7531-7536[Abstract/Free Full Text]
|
| 11.
|
Kaltschmidt, B.,
Uherek, M.,
Volk, B.,
Baeuerle, P. A.,
and Kaltschmidt, C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2642-2647[Abstract/Free Full Text]
|
| 12.
|
Lezoualc'h, F.,
Sagara, Y.,
Holsboer, F.,
and Behl, C.
(1998)
J. Neurosci.
18,
3224-3232[Abstract/Free Full Text]
|
| 13.
|
Koulich, E.,
Nguyen, T.,
Johnson, K.,
Giardina, C. A.,
and D'Mello, S. R.
(2001)
J. Neurochem.
76,
1188-1198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Maggirwar, S. B.,
Sarmiere, P. D.,
Dewhurst, S.,
and Freeman, R. S.
(1998)
J. Neurosci.
18,
10356-10365[Abstract/Free Full Text]
|
| 15.
|
Middleton, G.,
Hamanoue, M.,
Enokido, Y.,
Wyatt, S.,
Pennica, D.,
Jaffray, E.,
Hay, R. T.,
and Davies, A. M.
(2000)
J. Cell Biol.
148,
325-332[Abstract/Free Full Text]
|
| 16.
|
Mattson, M. P.,
Goodman, Y.,
Luo, H., Fu, W.,
and Furukawa, K.
(1997)
J. Neurosci. Res.
49,
681-697[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Tamatani, M.,
Che, Y. H.,
Matsuzaki, H.,
Ogawa, S.,
Okado, H.,
Miyake, S.,
Mizuno, T.,
and Tohyama, M.
(1999)
J. Biol. Chem.
274,
8531-8538[Abstract/Free Full Text]
|
| 18.
|
Yu, Z. F.,
Zhou, D.,
Bruce-Keller, A. J.,
Kindy, M. S.,
and Mattson, M. P.
(1999)
J. Neurosci.
19,
8856-8865[Abstract/Free Full Text]
|
| 19.
|
Kaltschmidt, B.,
Uherek, M.,
Wellmann, H.,
Volk, B.,
and Kaltschmidt, C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9409-9414[Abstract/Free Full Text]
|
| 20.
|
Grilli, M.,
Pizzi, M.,
Memo, M.,
and Spano, P. F.
(1996)
Science
274,
1383-1385[Abstract/Free Full Text]
|
| 21.
|
Qin, Z. H.,
Chen, R.-W.,
Wang, Y.,
Nakai, M.,
Chuang, D.-M.,
and Chase, T. N.
(1999)
J. Neurosci.
19,
4023-4033[Abstract/Free Full Text]
|
| 22.
|
Gosh, S.,
May, M. J.,
and Kopp, E. B.
(1998)
Annu. Rev. Immunol.
16,
225-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Schmitz, M. L.,
Bacher, S.,
and Kracht, M.
(2001)
Trends Biochem. Sci.
26,
186-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Perkins, N. D.
(1997)
Int. J. Biochem. Cell Biol.
29,
1433-1448[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Lin, S. C.,
Wortis, H. H.,
and Stavnezer, J.
(1998)
Mol. Cell. Biol.
18,
5523-5532[Abstract/Free Full Text]
|
| 26.
|
Roshak, A. K.,
Jackson, J. R.,
McGough, K.,
Chabot-Fletcher, M.,
Mochan, E.,
and Marshall, L. A.
(1996)
J. Biol. Chem.
271,
31496-31501[Abstract/Free Full Text]
|
| 27.
|
Grilli, M.,
Goffi, F.,
Memo, M.,
and Spano, P. F.
(1996)
J. Biol. Chem.
271,
15002-15007[Abstract/Free Full Text]
|
| 28.
|
Strijbos, P. J. L. M.,
and Rothwell, N. J.
(1995)
J. Neurosci.
15,
3468-3474[Abstract]
|
| 29.
|
Lipton, S. A.,
and Rosenberg, P. A.
(1994)
N. Engl. J. Med.
330,
613-622[Free Full Text]
|
| 30.
|
Pizzi, M.,
Galli, P.,
Consolandi, O.,
Arrighi, V.,
Memo, M.,
and Spano, P. F.
(1996)
Mol. Pharmacol.
49,
586-594[Abstract]
|
| 31.
|
Liou, H.-C.,
Jin, Z.,
Tumang, J.,
Andjelic, S.,
Smith, K. A.,
and Liou, M. L.
(1999)
Int. Immunol.
11,
361-371[Abstract/Free Full Text]
|
| 32.
|
Kaltschmidt, B.,
Uherek, M.,
Wellmann, H.,
Volk, B.,
and Kaltschmidt, C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9409-9414[Abstract/Free Full Text]
|
| 33.
|
Pizzi, M.,
Consolandi, O.,
Memo, M.,
and Spano, P. F.
(1996)
Eur. J. Neurosci.
8,
1516-1521[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Andrews, N. C.,
and Faller, D. V.
(1991)
Nucleic Acids Res.
19,
2499-2503[Free Full Text]
|
| 35.
|
Brooks, P. J.,
Marietta, C.,
and Goldman, D.
(1996)
J. Neurosci.
16,
939-945[Abstract/Free Full Text]
|
| 36.
|
Qin, Z.-H.,
Wang, Y.,
and Chasea, T. N.
(2000)
Mol. Brain Res.
80,
111-122[Medline]
[Order article via Infotrieve]
|
| 37.
|
Tam, W. F.,
and Sen, R.
(2001)
J. Biol. Chem.
276,
7701-7704[Abstract/Free Full Text]
|
| 38.
|
Heck, S.,
Lezoualc'h, F.,
Engert, S.,
and Behl, C.
(1999)
J. Biol. Chem.
274,
9828-9835[Abstract/Free Full Text]
|
| 39.
|
Israël, A.
(2000)
Trends Cell Biol.
10,
129-133[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Phelps, C. B.,
Sengchanthalangsy, L. L.,
Huxford, T.,
and Ghosh, G.
(2000)
J. Biol. Chem.
275,
29840-29846[Abstract/Free Full Text]
|
| 41.
|
Sizemore, N.,
Lerner, N.,
Dombrowski, N.,
Sakurai, H.,
and Stark, G. R.
(2002)
J. Biol. Chem.
277,
3863-3869[Abstract/Free Full Text]
|
| 42.
|
Chapman, N. R.,
and Perkins, N. D.
(2000)
J. Biol. Chem.
275,
4719-4725[Abstract/Free Full Text]
|
| 43.
|
Darville, M. I., Ho, Y. S.,
and Eizirik, D. L.
(2000)
Endocrinology
141,
153-162[Abstract/Free Full Text]
|
| 44.
|
Cheng, B.,
Christakos, S.,
and Mattson, M. P.
(1994)
Neuron
12,
139-153[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Stehlik, C.,
de Martin, R.,
Kumabashiri, I.,
Schmid, J. A.,
Binder, B. R.,
and Lipp, J.
(1998)
J. Exp. Med.
188,
211-216[Abstract/Free Full Text]
|
| 46.
|
Chen, C.,
Edelstein, L. C.,
and Gélinas, C.
(2000)
Mol. Cell. Biol.
20,
2687-2695[Abstract/Free Full Text]
|
| 47.
|
Grumont, R. J.,
Rourke, I. J.,
and Gerondakis, S.
(1999)
Genes Dev.
13,
400-411[Abstract/Free Full Text]
|
| 48.
|
Zong, W.-X.,
Edelstein, L. C.,
Chen, C.,
Bash, J.,
and Gelinas, C.
(1999)
Genes Dev.
13,
382-387[Abstract/Free Full Text]
|
| 49.
|
Owyang, A. M.,
Tumang, J. R.,
Schram, B. R.,
Hsia, C. Y.,
Behrens, T. W.,
Rothstein, T. L.,
and Liou, H. C.
(2001)
J. Immunol.
167,
4948-4956[Abstract/Free Full Text]
|
| 50.
|
Bernard, D.,
Quattannens, B.,
Begue, A.,
Vanderbunder, B.,
and Abbadie, C.
(2001)
Cancer Res.
61,
2656-2664[Abstract/Free Full Text]
|
| 51.
|
Qiu, J.,
Grafe, M. R.,
Schmura, S. M.,
Glasgow, J. N.,
Kent, T. A.,
Rassin, D. K.,
and Perez- Polo, J. R.
(2001)
J. Neurosci. Res.
64,
223-234[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
